Organon (OGN) Asset Utilization Ratio (2021 - 2026)

Organon (OGN) posted quarterly Asset Utilization Ratio of 0.48 for Q1 2026, down 0.59% year-over-year from 0.48 in Q1 2025, and up 1.28% on a QoQ basis from 0.47 in Q4 2025.

Organon (OGN) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Organon (OGN) has reported Asset Utilization Ratio for 6 consecutive years, with 0.48 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 0.59% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (down 0.59% YoY), while the FY2025 annual figure was 0.48, down 5.94% from the prior year.
  • Asset Utilization Ratio came in at 0.48 for Q1 2026 at Organon, up from 0.47 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.6 in Q2 2022, with the low at 0.47 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.53, with a median of 0.53 recorded in 2024.
  • Across the five-year window, Asset Utilization Ratio gained 5.29% in 2022 and retreated 10.72% in 2025, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.58 in 2022, then decreased by 5.94% to 0.54 in 2023, then dropped by 8.77% to 0.5 in 2024, then dropped by 5.0% to 0.47 in 2025, then rose by 1.28% to 0.48 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.48, 0.47, and 0.47 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 0.63
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.48
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 0.46
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 0.50
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 0.50
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 0.41
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.52
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.12
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 0.48

Historic Data

Download Data
DateValue
Mar 31, 2026 0.48
Dec 31, 2025 0.47
Sep 30, 2025 0.47
Jun 30, 2025 0.47
Mar 31, 2025 0.48
Dec 31, 2024 0.50
Sep 30, 2024 0.51
Jun 30, 2024 0.53
Mar 31, 2024 0.53
Dec 31, 2023 0.54
Sep 30, 2023 0.56
Jun 30, 2023 0.57
Mar 31, 2023 0.57
Dec 31, 2022 0.58
Sep 30, 2022 0.60
Jun 30, 2022 0.60
Mar 31, 2022 0.60
Dec 31, 2021 0.57
Sep 30, 2021 0.57
Jun 30, 2021 0.62